Safinamide for Parkinson's disease pain
Part of Brain & nervous system, Pain clinical trials.
This study tests whether safinamide, an add-on medication for Parkinson's disease, can reduce chronic pain in people who also experience motor fluctuations (times when symptoms return between doses). It aims to see if this treatment can improve pain and quality of life.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be at least 18 years old
- You have Parkinson's disease with pain lasting more than 3 months
- You have motor fluctuations (more than 1.5 hours of 'off' time each day) despite stable levodopa treatment
- Your Parkinson's symptoms respond to levodopa
- You have had pain in the last 12 weeks scoring at least 4 on a 0-10 pain scale
- You can speak and understand Italian and are willing to follow the study procedures
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether adding amantadine to usual Parkinson's medications can reduce the 'off' periods when symptoms return and movement becomes harder. It is for people with advanced Parkinson's who still have daily off periods despite their current treatment.
This study looks at how people with Parkinson’s, treated either with levodopa or deep brain stimulation (DBS), and healthy volunteers experience pain. The goal is to understand how Parkinson’s treatments affect pain perception.
This study tests a new single-dose treatment for Parkinson's disease to see if it can help reduce 'off' time—when medication wears off and symptoms return. It is for people who experience motor fluctuations and are already on a stable medication routine.
This study uses a special brain scan (PET) to look at the serotonin system in people with Parkinson's who have chronic pain. The goal is to understand why some people feel pain and how the brain chemical serotonin might be involved.
This study looks at pain in people with Parkinson's disease to understand how it relates to their condition and what it feels like. It may help improve pain management for Parkinson's patients.
This trial tests a new medication called Lu AF28996 to help reduce the periods when Parkinson's symptoms worsen throughout the day (called 'OFF times'). If you have motor fluctuations that are predictable and affecting your daily life, this study might help you experience fewer of these difficult periods.
Hear when a new PARKINSON DISEASE (Disorder) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.